[Strong lobbying for direct -to-consumer advertising of prescription drugs. Beneficial for the patient or for the increase of sales?].
Hjemdahl
Paul
P
Institutionen för medicin, enheten för klinisk farmakologi, Karolinska sjukhuset, Stockholm. paul.hjemdahl@ks.se
D000329:Advertising; D004345:Drug Industry / Q000706:statistics & numerical data; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D006801:Humans; D008119:Lobbying; D013548:Sweden; D014481:United States